000 01418 a2200397 4500
005 20250518070401.0
264 0 _c20200623
008 202006s 0 0 eng d
022 _a1872-6844
024 7 _a10.1016/j.eplepsyres.2019.106232
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKardoost, Masumeh
245 0 0 _aGenotoxicity assessment of antiepileptic drugs (AEDs) in human embryonic stem cells.
_h[electronic resource]
260 _bEpilepsy research
_c12 2019
300 _a106232 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnticonvulsants
_xtherapeutic use
650 0 4 _aCarbamazepine
_xtherapeutic use
650 0 4 _aDNA Damage
_xdrug effects
650 0 4 _aEpilepsy
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHuman Embryonic Stem Cells
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLamotrigine
_xpharmacology
650 0 4 _aLevetiracetam
_xpharmacology
650 0 4 _aPhenytoin
_xtherapeutic use
650 0 4 _aPregnancy
700 1 _aHajizadeh-Saffar, Ensiyeh
700 1 _aGhorbanian, Mohammad Taghi
700 1 _aGhezelayagh, Zahra
700 1 _aPooshang Bagheri, Kamran
700 1 _aBehdani, Mahdi
700 1 _aHabibi-Anbouhi, Mahdi
773 0 _tEpilepsy research
_gvol. 158
_gp. 106232
856 4 0 _uhttps://doi.org/10.1016/j.eplepsyres.2019.106232
_zAvailable from publisher's website
999 _c30293539
_d30293539